UM Ventures News
UM Ventures, Baltimore Newsletter | Summer 2026
Tuesday, July 28, 2026
Have an invention?Disclose it to the UM Ventures, Baltimore team. Featured Article An Internal Perspective of the Achievements of UMB Student Entrepreneurs Linda Petrillo, PhD, Research and Alliance Officer at University of Maryland, Baltimore (UMB), shares her... read more
Patent Awards | January - March 2026
Friday, July 24, 2026
Self-Expanding CannulaU.S. patent issued January 6, 2026 UMB inventors: Zhongjun Jon Wu, PhD; Bartley Griffith, MD Methods for Preventing Acute Kidney InjuryU.S. Continuation-in-Part issued January 6, 2026 UMB inventors: Mordecai P. Blaustein, MD; John M. Hamlyn, PhD; Stephen S. Gottlieb, MD... read more
A Legacy to UMB’s Research Commercialization: Gail Knott
Friday, July 24, 2026
For more than two decades, Gail Knott has been a central figure in the University of Maryland, Baltimore’s (UMB) Office of Research and Development (ORD), managing all aspects of technology transfer, including intellectual property (IP) and licensing compliance, commercial partnerships, and... read more
Inventor Spotlight: Yin Wang, PhD
Friday, July 24, 2026
Yin Wang, PhD, assistant professor in the University of Maryland School of Medicine’s Institute of Human Virology On the cutting edge of nanomedicine development, Yin Wang, PhD, assistant professor in the University of Maryland School of Medicine’s (UMSOM) Institute... read more
GlycoT Therapeutics
Friday, July 24, 2026
Founded in 2015 and based in Maryland, GlycoT Therapeutics is an emerging biotechnology company advancing next-generation biologics through precise glycoengineering. The joint University of Maryland, Baltimore (UMB) and University of Maryland, College Park (UMCP) startup company was built on... read more
Technology Transfer Guidance: UMB and VA Invention Management Agreement
Friday, July 24, 2026
More than 70 Veterans Affairs (VA) hospitals are located within five miles of a U.S. medical school. The Baltimore VA Medical Center is even closer, with a skybridge connecting it to the University of Maryland Medical Center, and more than 150 faculty members holding dual appointments between the... read more
An Internal Perspective of the Achievements of UMB Student Entrepreneurs
Thursday, July 23, 2026
By Linda Petrillo, PhD, Research and Alliance OfficerAs I sat in the audience at Nucleate’s 5th DMV Activator Demo Day on May 22, 2026, at the Pava Marie LaPere Center for Entrepreneurship at Johns Hopkins University, it was immediately clear that the University of Maryland, Baltimore (UMB)... read more
University System of Maryland Momentum Fund Invests in Alchemity
Tuesday, July 14, 2026
BALTIMORE (July 14, 2026) — The University System of Maryland Momentum Fund (Momentum Fund) has joined Alchemity’s Seed Financing round, alongside Blackbird Labs, Chesapeake Bay Seed Capital Fund, the Discovery Fund, District Angels, the Maryland Energy Innovation Accelerator through the Climate... read more
BioSpace: US FDA Grants Orphan Drug and Rare Pediatric Disease Designations to GEn1E Lifesciences’ Dual Signal Modulator for the Treatment of Duchenne Muscular Dystrophy
Tuesday, June 9, 2026
Dual FDA designations support advancement of GEn1E’s novel oral precision therapy GEn-1123 for a rare devastating neuromuscular disease with critical unmet need PALO ALTO, Calif.--(BUSINESS WIRE)--GEn1E Lifesciences Inc., a Phase 2 clinical-stage biotechnology company advancing AI-driven precision... read more
Secretome Therapeutics Announces $30 Million Series A Financing From RA Capital Management to Advance STM-01 for Duchenne-Associated Cardiomyopathy
Wednesday, May 27, 2026
Series A financing from RA Capital supports advancement of Secretome’s neonatal cardiac progenitor cell (nCPC) platform and planned Phase 2 and Phase 3 clinical trials of STM-01 in Duchenne muscular dystrophy-associated cardiomyopathy Industry veteran David Lubner joins Secretome’s Board of... read more